Mesothelioma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are currently being treated with one of the specific medications being studied (Atezolizumab, Nivolumab, Obinutuzumab, Durvalumab, Pembrolizumab, Daratumumab, or Cemiplimab) and have received at least two doses of it without any suspected allergic reactions.
- You have health insurance or are otherwise entitled to receive medical care.
- You are willing and able to sign a written consent form agreeing to take part.
- If you take steroid medications or certain antihistamines by injection or by mouth, you are able to stop taking them at least one week before the tests are carried out (inhaled steroids are allowed and do not need to be stopped).
Who may not be able to join:
- You have skin conditions (such as psoriasis or eczema) across part or all of your body that could make it difficult to read the results of skin tests.
- You do not have a sufficient understanding of the French language.
- You are currently pregnant or breastfeeding.
- You are currently being held in custody or detained by a legal or administrative decision.
- You are currently living in a health or social care facility for reasons unrelated to this research.
- You are currently under a legal protection order (for example, if someone else is legally appointed to make decisions on your behalf) (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Martine MORISSET, University Hospital, Angers
Phone: 02 41 35 36 37
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
maximum usable concentration considered non-irritant
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.